Skip to content
Home INFORMATION AT YOUR PACE

Medicare and Stem Cell Therapy: Covered Transplants Are Not Blanket Approval

Distinguish diagnosis-specific transplant benefits from unproven regenerative treatments, including arthritis claims, before relying on a coverage promise.

Explore this page

Medicare's coverage of certain stem cell transplants does not mean every service advertised as stem cell therapy is covered. The exact procedure, diagnosis and applicable coverage policy must be identified. An advertisement, testimonial or clinic's promise is not a Medicare coverage decision.

Doctor using a pulse oximeter during an examination

Two different situations

Situation Important distinction
Hematopoietic stem cell or bone marrow transplant Medicare has diagnosis-specific national coverage criteria, with additional requirements for some uses.
Advertised regenerative treatment for joints or other conditions Do not assume the transplant benefit applies or that the proposed treatment has regulatory approval.

What about arthritis?

The FDA's consumer information states that regenerative medicine therapies have not been approved to treat orthopedic conditions such as osteoarthritis. A clinic's claim that it is registered with the FDA, or that a treatment is listed on a clinical-trial website, does not establish approval.

Do not interpret Medicare's transplant coverage as coverage for an arthritis injection. Ask for the exact proposed service and the written Medicare or plan coverage basis before committing to payment. This article does not recommend an experimental treatment or substitute another treatment for your clinician's advice.

Questions before a financial commitment

  • What is the procedure, diagnosis and proposed billing code?
  • Which Medicare coverage rule applies to that specific use?
  • Is the treatment approved for the proposed purpose or part of a properly authorized study?
  • What does the written estimate identify as covered or self-pay?
  • Who can answer the coverage question independently of the selling clinic?

Use the correct review process

For a medically indicated transplant, the transplant center should review current Medicare criteria and any required study participation. Medicare Advantage members should also confirm the plan's access and authorization requirements.

If a claim is denied, obtain the actual reason and appeal instructions. A statement that a service is “promising” does not by itself establish payment. Discuss clinical risks and alternatives with a qualified treating professional.

Related coverage questions

Official sources

YOUR NEXT STEP STARTS HERE

Let’s figure it out together.

Our Agents

Compare your plan options

SunFire · Secure plan comparison
Open in a new tab ↗

Loading SunFire… If it takes a moment, you can open it in a new tab.